Lupin signs distribution agreements in key EU territories for orphan drug NaMuscla®

NEXT STORY
$3.72 Bn Bioanalytical Testing Services Market by Type, Application, End-user and Region – Forecast to 2025
PREV STORY
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Announces Investigation into Moderna, Inc. (MRNA) for Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Firm
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB (publ) (”Oasmia” or ”Company” or “Group”) on 18 April 2018 issued ...

author_avatar
NASDAQ Market News

Doctors prescribe diabetes treatment medications 15 times more than obesity drugs, study finds

SILVER SPRING, Md., Aug. 29, 2016 (GLOBE NEWSWIRE) -- Obesity is a well-established major ...

author_avatar
NASDAQ Market News

Apricus Biosciences Further Expands Existing Vitaros® Partnership with Ferring Pharmaceuticals in Europe and Asia

 Apricus Eligible to Receive an Additional $3.6 Million in Upfront and Pre-Commercialization Milestone Payments ...

author_avatar
NASDAQ Market News